Overview
Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.
Eligibility
Inclusion Criteria:
- Age ≥18 years
- Self-reported dermatologist-diagnosed psoriasis
- GAD 2-Item Score ≥1 at screening
- Ability to consent and complete pre- and post-intervention surveys.
- Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.
Exclusion Criteria:
- Severe hearing impairment precluding headphone listening
- Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe.
- Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.
